Cargando…
COVID‐19 and arterial hypertension: Hypothesis or evidence?
Investigations reported that hypertension, diabetes, and cardiovascular diseases were the most prevalent comorbidities among the patients with coronavirus disease 2019 (COVID‐19). Hypertension appeared consistently as the most prevalent risk factors in COVID‐19 patients. Some investigations speculat...
Autores principales: | Tadic, Marijana, Cuspidi, Cesare, Grassi, Guido, Mancia, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362072/ https://www.ncbi.nlm.nih.gov/pubmed/32627330 http://dx.doi.org/10.1111/jch.13925 |
Ejemplares similares
-
Coronavirus disease 2019 and cardiovascular complications: focused clinical review
por: Saeed, Sahrai, et al.
Publicado: (2021) -
White-Coat Hypertension: the Neglected Subgroup in Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2018) -
Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020) -
Hypertension and COVID-19: Ongoing Controversies
por: Tadic, Marijana, et al.
Publicado: (2021) -
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
por: Tadic, Marijana, et al.
Publicado: (2020)